Condition: Candidates for Hereditary Pancreatic Cancer Testing · Sponsor: Associazione Italiana per lo Studio del Pancreas
The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only. Participants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test. Up to 3,000 participants will be enrolled in this study.
This description comes directly from the study's public registry record.
Erica Secchettin, PharmD · 0458126254 · familiarita.aisp@gmail.com
AISP Association · 340 2713112 · aisp.ricerca@gmail.com
Always discuss trial participation with your own doctor first.
| Chirurgia generale e del Pancreas Azienda Ospedaliera Universitaria Integrata | Verona, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05724992